The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective average particle size of less than about 2000 nm.
申请公布号
KR20050026705(A)
申请公布日期
2005.03.15
申请号
KR20047019041
申请日期
2003.05.23
申请人
ELAN PHARMA INTERNATIONAL LIMITED;FOURNIER LABORATORIES IRELAND LIMITED
发明人
RYDE, TUULA;WILKINS, MICHAEL JOHN;JAIN, RAJEEV;PATEL, RAKESH;GUSTOW, EVAN E.;RUDDY, STEPHEN B.
